Holen Sie sich die Stockscreener-App
2.40
0.42%
0.010
Handel nachbörslich:
2.42
0.02
+0.83%
Immunitybio Inc Aktie (IBRX) Neueste Nachrichten
Real time scanner hits for ImmunityBio Inc. explainedQuarterly Earnings Summary & Weekly Sector Rotation Insights - Newser
What momentum shifts mean for ImmunityBio Inc.CPI Data & Advanced Technical Analysis Signals - Newser
A Closer Look at ImmunityBio (IBRX) Valuation Following Promising Early Results in Glioblastoma Study - Yahoo Finance
Is ImmunityBio Inc. stock technically oversold2025 Price Momentum & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Is ImmunityBio Inc. gaining market shareMarket Trend Report & Weekly Chart Analysis and Guides - خودرو بانک
Is ImmunityBio Inc. a speculative investment2025 Key Highlights & Free Fast Gain Swing Trade Alerts - 강소기업뉴스
Is ImmunityBio Inc. reversing from oversold territoryJuly 2025 Reactions & Technical Entry and Exit Alerts - Newser
ImmunityBio Inc. stock volume spike explainedJuly 2025 Action & Momentum Based Trading Ideas - Newser
How to build a custom watchlist for ImmunityBio Inc.Breakout Watch & Precise Swing Trade Entry Alerts - Newser
What’s next for ImmunityBio Inc. stock price2025 Biggest Moves & Daily Stock Trend Watchlist - Newser
Advanced analytics toolkit walkthrough for ImmunityBio Inc.Weekly Investment Recap & Weekly Breakout Stock Alerts - Newser
Applying chart zones and confluence areas to ImmunityBio Inc.Quarterly Portfolio Report & Expert Curated Trade Setups - Newser
ImmunityBio (IBRX) Reports 60% Revenue Growth as ANKTIVA Adoption Accelerates - MSN
ImmunityBio Inc. stock prediction for this week2025 Top Gainers & Technical Confirmation Trade Alerts - Newser
Using R and stats models for ImmunityBio Inc. forecasting2025 Price Action Summary & Low Risk Entry Point Tips - Newser
Will ImmunityBio Inc. bounce back from current supportJuly 2025 Patterns & Reliable Volume Spike Alerts - Newser
NK Cell Therapy Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, IND, and Companies - The Globe and Mail
Osteoarthritis Pipeline Analysis, 2025 by DelveInsight | ImmunityBio, Five Prime Therapeutics, Innate Pharma, Nektar Therapeutics, Cantargia, CureTech, Dynavax, Cellid Company, Kiadis Pharma, Multimmu - Barchart.com
What Went Wrong With ImmunityBio’s Executives Claims — and How Investors Could Still Win - TradingView
Detecting price anomalies in ImmunityBio Inc. with AIJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Is ImmunityBio Inc. stock entering bullish territory2025 Trading Volume Trends & Comprehensive Market Scan Insights - Newser
Measuring ImmunityBio Inc.’s beta against major indicesMarket Rally & Long-Term Growth Stock Strategies - Newser
Aug Sentiment: Can ImmunityBio Inc. stock double in the next yearWeekly Risk Summary & Advanced Technical Signal Analysis - خودرو بانک
Custom strategy builders for tracking ImmunityBio Inc.Bull Run & Technical Confirmation Trade Alerts - Newser
Should I hold or sell ImmunityBio Inc. nowJuly 2025 Action & High Accuracy Buy Signal Tips - خودرو بانک
Is ImmunityBio Inc. stock a smart retirement pickJuly 2025 Volume & Momentum Based Trading Ideas - khodrobank.com
What are the analyst revisions for DRUGIs ImmunityBio Inc. stock a good investment in YEARTrade Exit Summary & Real-Time Volume Analysis - خودرو بانک
Should value investors consider ImmunityBio Inc.July 2025 Sector Moves & Precise Trade Entry Recommendations - خودرو بانک
Can ImmunityBio Inc. stock double in the next year2025 Market Overview & AI Driven Price Predictions - خودرو بانک
Does ImmunityBio Inc. have high return on assetsTreasury Yields & Risk Managed Investment Strategies - خودرو بانک
Is ImmunityBio Inc.’s growth already priced inJuly 2025 Volume & Verified Stock Trade Ideas - خودرو بانک
ImmunityBio Inc. Charts Flash Early Recovery SignalsJuly 2025 Setups & Risk Controlled Stock Pick Alerts - beatles.ru
Does ImmunityBio Inc. have a sustainable dividendTrade Performance Summary & Step-by-Step Swing Trade Plans - خودرو بانک
Fed Meeting: Is ImmunityBio Inc. forming a double bottomWeekly Trade Report & Safe Capital Investment Plans - خودرو بانک
Trend Report: Is ImmunityBio Inc.’s growth already priced inMarket Growth Review & Real-Time Buy Signal Notifications - خودرو بانک
Identifying reversal signals in ImmunityBio Inc.2025 Key Lessons & Technical Pattern Based Signals - Newser
What technical models suggest about ImmunityBio Inc.’s comeback2025 Technical Overview & Free Risk Controlled Daily Trade Plans - Newser
What’s ImmunityBio Inc.’s historical returnWeekly Volume Report & Trade Opportunity Analysis - خودرو بانک
Is ImmunityBio Inc. stock a value trapQuarterly Trade Summary & Stepwise Entry/Exit Trade Alerts - خودرو بانک
Comparing ImmunityBio Inc. in custom built stock radarsEarnings Growth Summary & Weekly Chart Analysis and Guides - Newser
ImmunityBio Inc. Chart Enters High Volatility Zone2025 Biggest Moves & High Return Stock Watch Alerts - beatles.ru
Neuroendocrine tumors Pipeline Analysis, 2025 by DelveInsight | RayzeBio, Inc., Camurus, Vyriad, Inc., ADC Therapeutics, Eli Lilly and Company, Biotheus Inc., ImmunityBio, Inc., Chimerix, Merck Sharp - Barchart.com
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):